Form 4: Bicycle Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Michael Skynner, CHIEF SCIENTIFIC OFFICER of Bicycle Therapeutics Plc, sold 2,445 shares of common stock on October 2, 2026.
Summary
- Open-market sale: disposed of 1,942 Ordinary Shares at $3.47 ($6,739) on October 2, 2026; holds 155,229 after (Direct).
- Open-market sale: disposed of 503 Ordinary Shares at $3.57 ($1,796) on October 5, 2026; holds 154,726 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $8,534 of stock on the open market.
Insider Transactions
Michael Skynner — Officer (CHIEF SCIENTIFIC OFFICER)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-02 | Open-market sale | Ordinary Shares | 1,942 | $3 | $6.7K | 155,229 |
| 2026-10-05 | Open-market sale | Ordinary Shares | 503 | $4 | $1.8K | 154,726 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Open-market sale (1,942 shares) |
| 2026-10-05 | Open-market sale (503 shares) |
Keywords
insider transaction, Form 4, BCYC, BICYCLE THERAPEUTICS PLC, bearish, Michael Skynner
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.